News

EyePoint Pharmaceuticals Prepares for Investor Conferences

EyePoint Pharmaceuticals Prepares for Investor Conferences

EyePoint Pharmaceuticals Gears Up for Investor Conferences

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company dedicated to developing and commercializing innovative treatments for patients with serious retinal diseases, has announced its participation in several important upcoming investor conferences.

Upcoming Conferences

The management team will be attending the following significant events:

Morgan Stanley Annual Global Healthcare Conference

This conference will include one-on-one meetings with investors, providing an opportunity for direct engagement with company representatives. It is scheduled for an upcoming Wednesday.

Baird Global Healthcare Conference

At this conference, EyePoint Pharmaceuticals will participate in a fireside chat, sharing insights about the company's progress and future strategies. This event is set for the coming Tuesday at 4:20 p.m. ET.

Cantor Global Healthcare Conference

During the fireside chat at this conference, EyePoint will delve deeper into its pipeline and product candidates. This event is planned for a Wednesday at 11:30 a.m. ET.

UBS Virtual Ophthalmology Day

This virtual event will also feature a fireside chat with EyePoint Pharmaceuticals, scheduled for a Wednesday at 2:30 p.m. ET.

Webcast Availability

A live webcast of the discussions, along with an archived replay, will be available in the Investors section of the company's official website.

About EyePoint Pharmaceuticals

EyePoint Pharmaceuticals specializes in innovative treatments for serious retinal diseases. The company's pipeline is primarily supported by its proprietary bioerodible Durasert E™ technology, which allows for sustained drug delivery within the eye. Its leading product candidate, DURAVYU™ (formerly known as EYP-1901), marks a significant advancement in the treatment of VEGF-mediated retinal diseases. This investigational drug combines vorolanib, a selective tyrosine kinase inhibitor, with Durasert E™ technology to ensure continuous drug release.

Current Research and Development

DURAVYU is currently undergoing Phase 2 clinical trials aimed at addressing conditions such as wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME), which are among the leading causes of vision loss in older adults in the United States. EyePoint anticipates starting pivotal Phase 3 trials for wet AMD in the near future.

Additional Pipeline Products

EyePoint’s pipeline also features EYP-2301, a promising TIE-2 agonist formulation designed to improve outcomes for patients with serious retinal conditions. The Durasert® technology has been successfully utilized in four FDA-approved products, demonstrating its efficacy and safety.

Licensing Agreements

Vorolanib, a crucial component of EyePoint's therapies, is exclusively licensed from Equinox Sciences, part of the Betta Pharmaceuticals group, for the treatment of localized ophthalmic diseases.

Contact Information for Investors and Media

If you are an investor and have inquiries, please contact:

Christina Tartaglia
Precision AQ
Direct: 212-698-8700
christina.tartaglia@precisionaq.com

For media inquiries, please reach out to:

Amy Phillips
Green Room Communications
Direct: 412-327-9499
aphillips@greenroompr.com

Frequently Asked Questions

What is EyePoint Pharmaceuticals known for?

EyePoint Pharmaceuticals is a clinical-stage biopharmaceutical company that focuses on developing innovative therapeutics for serious retinal diseases.

What are the key upcoming events for EyePoint Pharmaceuticals?

EyePoint is set to participate in several investor conferences, including those hosted by Morgan Stanley, Baird, Cantor, and UBS.

What is the lead product candidate of EyePoint Pharmaceuticals?

The lead product candidate is DURAVYU™, an investigational sustained delivery treatment for VEGF-mediated retinal diseases.

What technologies does EyePoint Pharmaceuticals utilize?

The company employs its proprietary bioerodible Durasert E™ technology to ensure sustainable drug delivery within the eye.

Where can I find more information about EyePoint Pharmaceuticals?

Additional information is available on the company's official website and during their upcoming investor presentations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Pigeon Unveils Green Innovations at CIIE 2026

Updated Category News Views 204

An International Celebration: Cultural Connections at CIIE Babies have a way of bringing the world together. Every culture has its own quirks and traditions, but the love for a newborn is common ground. Pigeon gets that, and they're putting it on full display at the China International Import Expo (CIIE) in Shanghai. It's their fourth run at this rodeo, and they’re not...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 178

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 253

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 227

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 149

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
7th World Media Summit Spotlights Media's Future in Beijing

Updated Category News Views 140

The Changing Landscape of Global Media An event of this magnitude doesn't just pop up every day like a stock ticker on Wall Street. This year's 7th World Media Summit in Beijing is where nearly 500 bigwigs from all corners of the media landscape are converging. It's not about trading stocks or hitting quarterly numbers—it's about shaping how stories get told in an era...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 212

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Sensitron's 270VDC SSPCs: A Power System Shake-Up

Updated Category News Views 333

Revolutionizing Power Distribution with Sensitron Some days, the tech world dishes out real game-changers, and looks like November 6, 2026, was one of those days. Sensitron Semiconductor dropped a bombshell with their SPHM/SEHM Series—a brand-new lineup of programmable 16-channel Solid State Power Controllers (SSPCs). Tailored for the grueling demands of 270VDC power...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 163

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 180

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading

Top 5 Most Recently Viewed Articles

Syntec Optics Reaches Major Achievement in Space Optics Production

Updated Category News Views 154

Syntec Optics Celebrates Production Milestone Syntec Optics Holdings, Inc. (NASDAQ: OPTX) has recently achieved a monumental milestone in its production line by manufacturing its 17,000th satellite optic. This accomplishment marks a significant step for the company, which stands as a leader in developing technology products across various sectors, including defense,...

Continue Reading
Exploring the Growth of the Global Burn Care Industry

Updated Category News Views 212

The Expansion of the Burn Care Market The global Burn Care Market has witnessed remarkable growth, valued at approximately US$2.46 billion in recent evaluations. Forecasts indicate this figure is set to increase significantly, reaching an impressive US$3.35 billion by the end of the decade. This growth is primarily influenced by various factors contributing to the rising...

Continue Reading
DCS Corporation Triumphs with OASIS+ Contract Award

Updated Category News Views 154

DCS Corporation Triumphs with OASIS+ Contract Award DCS Corporation has recently celebrated a pivotal achievement by securing an unrestricted prime contract under the General Services Administration's One Acquisition Solution for Integrated Services Plus (OASIS+). This noteworthy award spans all four key service domains: Management & Advisory, Technical & Engineering,...

Continue Reading
Meta's AI-Powered Glasses Surge in Popularity and Demand

Updated Category News Views 159

Overview of Meta's AI Glasses Innovation Meta Platforms has recently made headlines with the launch of its cutting-edge artificial intelligence (AI) glasses, known as the Meta Ray-Ban Display. These smart glasses combine stylish design with advanced technology, featuring a built-in display and a neural wristband that allows users to control the device through intuitive...

Continue Reading
Smartmatic's $2.7 Billion Lawsuit Against Fox News Moves Forward

Updated Category News Views 266

Smartmatic's Legal Challenge Against Fox News In a significant ruling, a New York state appeals court has decided that Fox News must confront a $2.7 billion defamation lawsuit brought forth by Smartmatic, a voting machine company. This lawsuit stems from allegations made on air related to the contentious 2020 U.S. presidential election, leading to serious legal...

Continue Reading